Nuo Therapeutics, Inc.
AURX
$1.24
$0.010.78%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.10M | 1.03M | 700.20K | 484.40K | 394.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.10M | 1.03M | 700.20K | 484.40K | 394.90K |
| Cost of Revenue | 408.50K | 406.70K | 159.40K | 121.00K | 86.40K |
| Gross Profit | 688.40K | 625.40K | 540.90K | 363.40K | 308.50K |
| SG&A Expenses | 1.27M | 1.17M | 1.19M | 1.11M | 937.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.68M | 1.57M | 1.35M | 1.23M | 1.02M |
| Operating Income | -579.30K | -540.10K | -652.00K | -745.10K | -629.20K |
| Income Before Tax | -578.50K | -537.90K | -649.70K | -746.10K | -496.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -578.50K | -537.90K | -649.70K | -746.10K | -496.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -578.50K | -537.90K | -649.70K | -746.10K | -496.70K |
| EBIT | -579.30K | -540.10K | -652.00K | -745.10K | -629.20K |
| EBITDA | -555.40K | -517.00K | -629.00K | -729.80K | -617.70K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 48.06M | 47.54M | 46.82M | 46.82M | 47.18M |
| Average Diluted Shares Outstanding | 48.06M | 47.54M | 46.82M | 46.82M | 47.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |